These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 37723020)
1. Intraoperative Versus Postoperative Hydroxocobalamin for Vasoplegic Shock in Cardiothoracic Surgery. Khandekar DA; Seelhammer TG; Mara KC; Stephens EH; Wittwer ED; Wieruszewski PM J Cardiothorac Vasc Anesth; 2023 Dec; 37(12):2538-2545. PubMed ID: 37723020 [TBL] [Abstract][Full Text] [Related]
2. Hydroxocobalamin or Methylene Blue for Vasoplegic Syndrome in Adult Cardiothoracic Surgery. Kram SJ; Kram BL; Cook JC; Ohman KL; Ghadimi K J Cardiothorac Vasc Anesth; 2022 Feb; 36(2):469-476. PubMed ID: 34176677 [TBL] [Abstract][Full Text] [Related]
3. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management. Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716 [TBL] [Abstract][Full Text] [Related]
4. Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass. Peyko V; Finamore M Am J Case Rep; 2021 Jun; 22():e930890. PubMed ID: 34143764 [TBL] [Abstract][Full Text] [Related]
5. Predicting the Response of Hydroxocobalamin in Postoperative Vasoplegia in Recipients of Cardiopulmonary Bypass. Vollmer N; Wieruszewski PM; Martin N; Seelhammer T; Wittwer E; Nabzdyk C; Mara K; Nei SD J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):2908-2916. PubMed ID: 35181236 [TBL] [Abstract][Full Text] [Related]
6. Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series. Armour S; Armour TK; Joppa WR; Maltais S; Nelson JA; Wittwer E Anesth Analg; 2019 Jul; 129(1):e1-e4. PubMed ID: 29979199 [TBL] [Abstract][Full Text] [Related]
7. Factors associated with vasoplegic shock in the postoperative period of cardiac surgery and influence on morbidity and mortality of the use of arginine vasopressin as rescue therapy. Barrera Sánchez M; Royo Villa C; Ruiz de Gopegui Miguelena P; Gutiérrez Ibañes P; Carrillo López A Med Intensiva (Engl Ed); 2024 Jul; 48(7):392-402. PubMed ID: 38697904 [TBL] [Abstract][Full Text] [Related]
8. Extended duration infusion of high-dose hydroxocobalamin for vasoplegic syndrome following cardiac surgery. Seelhammer TG; Plack D; Nei S; Wittwer E; Nelson J; Nabzdyk CGS Heart Lung; 2021; 50(2):173-176. PubMed ID: 33242823 [TBL] [Abstract][Full Text] [Related]
9. Hydroxocobalamin Versus Methylene Blue for Vasoplegic Syndrome in Cardiothoracic Surgery: A Retrospective Cohort. Furnish C; Mueller SW; Kiser TH; Dufficy L; Sullivan B; Beyer JT J Cardiothorac Vasc Anesth; 2020 Jul; 34(7):1763-1770. PubMed ID: 32115360 [TBL] [Abstract][Full Text] [Related]
10. Effects of norepinephrine infusion during cardiopulmonary bypass on perioperative changes in lactic acid level (Norcal). Khalil MA; El Tahan MR; Khidr AM; Fallatah S; Abohamar AD; Amer MM; Makhdom F; El Ghoneimy Y; Al Bassam B; Alghamdi T; Abdulfattah D Perfusion; 2023 Nov; 38(8):1584-1599. PubMed ID: 35994013 [TBL] [Abstract][Full Text] [Related]
11. Hydroxocobalamin Versus Methylene Blue for the Treatment of Vasoplegic Shock Associated With Cardiopulmonary Bypass. Hiruy A; Ciapala S; Donaldson C; Wang L; Hohlfelder B J Cardiothorac Vasc Anesth; 2023 Nov; 37(11):2228-2235. PubMed ID: 37586951 [TBL] [Abstract][Full Text] [Related]
12. Vasoplegia During Cardiopulmonary Bypass: Current Literature and Rescue Therapy Options. Ortoleva J; Shapeton A; Vanneman M; Dalia AA J Cardiothorac Vasc Anesth; 2020 Oct; 34(10):2766-2775. PubMed ID: 31917073 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D and Postoperative Vasopressor Use in Cardiopulmonary Bypass. Javorski MJ; Kerolos MM; Fareed J; Perez-Tamayo RA Clin Appl Thromb Hemost; 2018 Nov; 24(8):1322-1326. PubMed ID: 29730947 [TBL] [Abstract][Full Text] [Related]
14. The use of high-dose hydroxocobalamin for vasoplegic syndrome. Roderique JD; VanDyck K; Holman B; Tang D; Chui B; Spiess BD Ann Thorac Surg; 2014 May; 97(5):1785-6. PubMed ID: 24792267 [TBL] [Abstract][Full Text] [Related]
15. Use of Intravenous Hydroxocobalamin for Vasoplegic Syndrome in Simultaneous Liver-Kidney Transplant: A Case Report. Weinberg D; Running K; Kalarickal PL; Patel GP Transplant Proc; 2021 May; 53(4):1300-1302. PubMed ID: 33246585 [TBL] [Abstract][Full Text] [Related]
16. Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study. Feih JT; Rinka JRG; Zundel MT J Cardiothorac Vasc Anesth; 2019 May; 33(5):1301-1307. PubMed ID: 30606508 [TBL] [Abstract][Full Text] [Related]
17. Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case series. Shah PR; Reynolds PS; Pal N; Tang D; McCarthy H; Spiess BD Can J Anaesth; 2018 May; 65(5):560-568. PubMed ID: 29209927 [TBL] [Abstract][Full Text] [Related]
18. The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery. Cai Y; Mack A; Ladlie BL; Martin AK Ann Card Anaesth; 2017; 20(4):462-464. PubMed ID: 28994688 [TBL] [Abstract][Full Text] [Related]
19. Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome. Levin MA; Lin HM; Castillo JG; Adams DH; Reich DL; Fischer GW Circulation; 2009 Oct; 120(17):1664-71. PubMed ID: 19822810 [TBL] [Abstract][Full Text] [Related]
20. Hydroxocobalamin for Vasodilatory Hypotension in Shock: A Systematic Review With Meta-Analysis for Comparison to Methylene Blue. Brokmeier HM; Seelhammer TG; Nei SD; Gerberi DJ; Mara KC; Wittwer ED; Wieruszewski PM J Cardiothorac Vasc Anesth; 2023 Sep; 37(9):1757-1772. PubMed ID: 37147207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]